Searched for
EMCURE PHARMA IPO
Bain Capital sole contender for Vitabiotics buyBain Capital has emerged as the frontrunner to acquire Vitabiotics, as rival bidders TPG Capital and EQT exit the process, potentially lowe...- Emcure Pharma shares in focus as Bain Capital likely to offload 2.4% stake via block dealBC Investments IV, linked to Bain Capital, is expected to sell a 2.4% stake in Emcure Pharmaceuticals. The sale will occur through a block ...
- Emcure Pharma IPO GMP: Street anticipates a robust listing tomorrow. Will it trump expectations?Emcure Pharmaceuticals' shares to debut on stock exchanges with a GMP of Rs 360. Analysts bullish on both short-term and long-term gains. C...
- Emcure Pharmaceuticals IPO booked nearly 68 times so far on Day 3. Check GMP and other detailsEmcure Pharmaceuticals IPO sees strong demand with oversubscription. Anchor investors include top names. Company engaged in global pharmace...
- Namita Thapar-backed Emcure Pharma IPO opens for subscription. Should you bid?Emcure Pharma IPO: Emcure Pharmaceuticals IPO, with marquee investors like Goldman Sachs, offers a fresh equity issuance and OFS. Namita Th...
- Emcure Pharmaceuticals IPO fully subscribed on Day 1. Check GMP and other detailsEmcure Pharmaceuticals' IPO attracts high demand from investors, with a price range of Rs 960-1008 per share. Analysts foresee business imp...
- Emcure Pharmaceuticals IPO booked nearly 5x so far on Day 2. Check GMP and other detailsEmcure Pharmaceuticals' IPO has been oversubscribed nearly three times as of Thursday, the second day of bidding. The bidding concludes on ...
- Shark tank fame Namita Thapar to rake in Rs 127 crore through Emcure Pharma IPOShark Tank's Namita Thapar, who is part of Emcure Pharmaceuticals' promoter group, is set to earn approximately Rs 127 crore through the up...
- IPO Analysis: Emcure has better-listed pharma alternativesEmcure Pharma, with its strong presence in gynaecology and HIV therapeutic areas, secured significant investments from anchor investors lik...
- Bain Capital-backed Emcure Pharma mobilises Rs 583 cr from anchor investorsEmcure Pharmaceuticals has allocated 57.8 lakh equity shares to 48 funds at the upper end of the IPO price band, raising Rs 582.6 crore. Th...
- Namita Thapar's Emcure Pharmaceuticals IPO opens on Wednesday. What GMP signals ahead of subscriptionEmcure Pharmaceuticals' IPO opens for subscription on July 3rd with shares trading at a Rs 265 premium in the unlisted market. The IPO incl...
- Emcure Pharmaceuticals IPO: 10 things to know before subscribing to the issueEmcure Pharmaceuticals IPO is scheduled to open for subscription on July 3 and will close on July 5. The company aims to raise approximatel...
- Emcure Pharma announces price band for Rs 1,952-crore IPO at Rs 960-1,008/share. Check GMP, other detailsEmcure Pharmaceuticals has announced its initial public offering (IPO) with a price band of Rs 960 to Rs 1,008 per equity share. The subscr...
- Bain Capital-backed Emcure Pharma to float IPO on July 3Emcure Pharmaceuticals, backed by Bain Capital, is set to launch its IPO on July 3. The IPO includes fresh equity shares issuance and Offer...
- Ola Electric, Emcure Pharma get Sebi nod for IPOs, setting stage for big listingsThe Bengaluru-based company had filed its draft prospectus with Sebi in December last year. The issue comprises a fresh equity sale of Rs 5...
- Emcure Pharma to launch IPO in 3 months: Namita Thapar of Shark Tank fameShark Tank fame and Executive Director of Emcure Pharmaceuticals, Namita Thapar said at the ET NOW Global Business Summit 2024 on February ...
- Emcure Pharmaceuticals gets Sebi's go-ahead to float IPOAs part of the OFS, promoters — Satish Mehta will offload 20.30 lakh equity shares, Sunil Mehta will sell 2.5 lakh equity shares — and inve...
- Emcure to soon file papers for Rs 4,000 crore IPOThe IPO will consist of a primary issue and offer for sale from its promoter Satish Mehta and existing investor Bain Capital which acquired...
- Generics company Emcure plans Rs 4,000 crore IPOEmcure may appoint as many as six bankers for the IPO including JM Financial, Kotak Capital, Axis Capital and SBI Capital, the people said....
- Emcure Pharmaceuticals withdraws proposed IPOThe Pune-based pharma company had filed draft offer documents with the Securities and Exchange Board of India (Sebi) for the proposed IPO i...
Load More
